Immunicum AB (DE:1YG0)
FRANKFURT:1YG0
Germany Market
Holding DE:1YG0?
Track your performance easily

Immunicum AB (1YG0) Financial Statements

1 Followers

Immunicum AB Financial Overview

Immunicum AB's market cap is currently ―. The company's EPS TTM is €-3.538; its P/E ratio is -0.25; Immunicum AB is scheduled to report earnings on November 8, 2024, and the estimated EPS forecast is €-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenuekr 0.00kr 0.00kr 1.79Mkr 0.00kr 0.00
Gross Profit-----
EBITkr -37.38Mkr -28.10Mkr -26.64Mkr -31.77Mkr -26.30M
EBITDAkr -35.89Mkr -28.10Mkr -26.64Mkr -31.77Mkr -26.30M
Net Income Common Stockholderskr -38.60Mkr -29.32Mkr -27.58Mkr -32.84Mkr -26.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 55.40Mkr 84.86Mkr 122.93Mkr 155.31Mkr 181.50M
Total Assetskr 652.22Mkr 685.36Mkr 718.88Mkr 720.98Mkr 744.66M
Total Debtkr 26.49Mkr 26.18Mkr 25.83Mkr 36.98Mkr 536.00K
Net Debtkr -28.92Mkr -58.68Mkr -97.10Mkr -118.34Mkr -180.97M
Total Liabilitieskr 91.07Mkr 85.02Mkr 89.62Mkr 64.24Mkr 55.67M
Stockholders Equitykr 561.15Mkr 600.34Mkr 629.26Mkr 656.74Mkr 688.99M
Cash Flow-
Free Cash Flowkr -27.82Mkr -39.92Mkr -32.21Mkr -25.67Mkr -29.30M
Operating Cash Flowkr -27.82Mkr -36.28Mkr -23.89Mkr -25.62Mkr -29.27M
Investing Cash Flowkr 1.33Mkr -3.39Mkr -8.33Mkr -45.00Kkr -36.00K
Financing Cash Flowkr -3.20Mkr 1.57Mkr -346.00Kkr -508.00Kkr -1.05M
Currency in SEK

Immunicum AB Earnings and Revenue History

Immunicum AB Debt to Assets

Immunicum AB Cash Flow

Immunicum AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis